LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
1. A class action complaint against LFCR was filed on July 29, 2024. 2. Investors are encouraged to discuss potential claims regarding fiduciary duties breach. 3. Allegations include misleading statements about financial reporting and internal controls. 4. LFCR's financial statements may need significant restatements due to inaccuracies. 5. The investigation could affect LFCR's compliance with NASDAQ listing requirements.